Groundbreaking research has led to the first clinical trial to evaluate the safety of cord blood stem cell treatments for hearing loss. According to a study published in Cell Transplantation, animal subjects treated with cord blood stem cells showed significant healing to the damaged sensory hair cells and neurons in the inner ear. Dr. James Baumgartner, pediatric neurosurgeon, and colleagues at Children’s Memorial Hermann Hospital in Houston will launch the first FDA-regulated clinical trial evaluating the use of cord blood stem cell treatments for children with hearing loss.
A report released by the U.S. Department of Housing and Urban Development (HUD) reveals that discrimination based on a person’s disability continued to be the largest single category of fair housing discrimination complaints filed in fiscal year 2010.
People with hearing loss seem to be among those who love the latest and greatest technology. Early adopters of email, IM, smartphones and text messaging, we are thrilled with world that provides tech solutions for communication problems.